Youssefzadeh, Ariane C.
Matsuzaki, Shinya
Mandelbaum, Rachel S.
Sangara, Rauvynne N.
Bainvoll, Liat
Matsushima, Kazuhide
Ouzounian, Joseph G.
Matsuo, Koji http://orcid.org/0000-0002-6232-8701
Funding for this research was provided by:
Ensign Endowment for Gynecologic Cancer Research
Article History
Received: 18 September 2021
Accepted: 27 December 2021
First Online: 24 January 2022
Declarations
:
: All were outside the work: honorarium, Chugai, textbook editorial expense, Springer, investigator meeting attendance expense, VBL Therapeutics (Ko.M.); research grant, Merck (S.M.); none for others.
: University of Southern California Institutional Review Board exemption (HS-16–00,481).
: Not applicable.
: Not applicable.
: The manuscript’s corresponding author (Ko.M.) affirms that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained. The National Inpatient Sample classified the race/ethnicity, and the current study used the default grouping for analysis.